Application of ANXA11 and anpep in serum exosomes in preparing products for diagnosis of pancreatic cancer
NL2039136B1Active Publication Date: 2026-06-15AFFILIATED HOSPITAL OF NANTONG UNIV
Patent Information
- Authority / Receiving Office
- NL · NL
- Patent Type
- Patents
- Current Assignee / Owner
- AFFILIATED HOSPITAL OF NANTONG UNIV
- Filing Date
- 2024-11-22
- Publication Date
- 2026-06-15
Abstract
The present invention relates to the application of proteins ANXAll and.ANPEP in serum exosomes in preparing products for the diagnosis of pancreatic cancer (PC). The present invention enables early, accurate, and efficient diagnosis of PC by direct detection of the PC markers ANXAll and ANPEP in the serum exosomes, providing a basis for early diagnosis, treatment monitoring, and. prognosis of PC with. proteins ANXAll and ANPEP in serum exosomes.
Need to check novelty before this filing date? Find Prior Art